|
"tai i c"的相关文件
显示项目 1-8 / 8 (共1页)
1
每页显示[10|25|50]项目
| 國立成功大學 |
2023 |
A Retrospective Study of the Safety and Immunogenicity of MVC-COV1901 Vaccine for People Living with HIV
|
Cheng, S.-H.;Lien, C.E.;Hsieh, S.-M.;Cheng, Cheng C.-Y.;Liu, W.-D.;Lo, C.-L.;Ko, W.-C.;Chen, Y.-H.;Huang, C.-T.;Chang, H.-T.;Hwang, S.-J.;Wang, N.-C.;Liu, M.-C.;Lee, Y.-L.;Tai, I.-C.;Estrada, J.A.G.;Lin, T.-Y.;Lee, W.-S. |
| 臺大學術典藏 |
2021-12-02T05:41:26Z |
Safety and immunogenicity of a Recombinant Stabilized Prefusion SARS-CoV-2 Spike Protein Vaccine (MVC[sbnd]COV1901) Adjuvanted with CpG 1018 and Aluminum Hydroxide in healthy adults: A Phase 1, dose-escalation study
|
Hsieh S.-M.; WANG-DA LIU; Huang Y.-S.; Lin Y.-J.; Hsieh E.-F.; Lian W.-C.; Chen C.; Janssen R.; Shih S.-R.; Huang C.-G.; Tai I.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-24T08:23:28Z |
Safety and immunogenicity of a Recombinant Stabilized Prefusion SARS-CoV-2 Spike Protein Vaccine (MVC[sbnd]COV1901) Adjuvanted with CpG 1018 and Aluminum Hydroxide in healthy adults: A Phase 1, dose-escalation study
|
Hsieh S.-M.; Liu W.-D.; YU-SHAN HUANG; Lin Y.-J.; Hsieh E.-F.; Lian W.-C.; Chen C.; Janssen R.; Shih S.-R.; Huang C.-G.; Tai I.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-20T07:38:57Z |
Safety and immunogenicity of a Recombinant Stabilized Prefusion SARS-CoV-2 Spike Protein Vaccine (MVC[sbnd]COV1901) Adjuvanted with CpG 1018 and Aluminum Hydroxide in healthy adults: A Phase 1, dose-escalation study
|
SZU-MIN HSIEH; Liu W.-D.; Huang Y.-S.; Lin Y.-J.; Hsieh E.-F.; Lian W.-C.; Chen C.; Janssen R.; Shih S.-R.; Huang C.-G.; Tai I.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-20T04:24:49Z |
Safety and immunogenicity of a Recombinant Stabilized Prefusion SARS-CoV-2 Spike Protein Vaccine (MVC[sbnd]COV1901) Adjuvanted with CpG 1018 and Aluminum Hydroxide in healthy adults: A Phase 1, dose-escalation study
|
Hsieh S.-M.; Liu W.-D.; Huang Y.-S.; Lin Y.-J.; Hsieh E.-F.; Lian W.-C.; Chen C.; Janssen R.; Shih S.-R.; Huang C.-G.; Tai I.-C.; SHAN-CHWEN CHANG |
| 臺大學術典藏 |
2021-06-24T07:16:12Z |
Immunogenicity, safety, cross-reaction, and immune persistence of an inactivated enterovirus A71 vaccine in children aged from two months to 11 years in Taiwan
|
Li-Min Huang;Chiu C.-H.;Chiu N.-C.;Lin C.-Y.;Li M.-T.;Kuo T.-Y.;Weng Y.-J.;Hsieh E.-F.;Tai I.-C.; LI-MIN HUANG; Chiu C.-H.; Chiu N.-C.; Lin C.-Y.; Li M.-T.; Kuo T.-Y.; Weng Y.-J.; Hsieh E.-F.; Tai I.-C. |
| 臺大學術典藏 |
2021-06-24T07:16:12Z |
Immunogenicity, safety, cross-reaction, and immune persistence of an inactivated enterovirus A71 vaccine in children aged from two months to 11 years in Taiwan
|
Li-Min Huang;Chiu C.-H.;Chiu N.-C.;Lin C.-Y.;Li M.-T.;Kuo T.-Y.;Weng Y.-J.;Hsieh E.-F.;Tai I.-C.; LI-MIN HUANG; Chiu C.-H.; Chiu N.-C.; Lin C.-Y.; Li M.-T.; Kuo T.-Y.; Weng Y.-J.; Hsieh E.-F.; Tai I.-C. |
| 國立成功大學 |
2021 |
Safety and immunogenicity of CpG 1018 and aluminium hydroxide-adjuvanted SARS-CoV-2 S-2P protein vaccine MVC-COV1901: interim results of a large-scale, double-blind, randomised, placebo-controlled phase 2 trial in Taiwan
|
Hsieh, S.-M.;Liu, M.-C.;Chen, Y.-H.;Lee, W.-S.;Hwang, S.-J.;Cheng, S.-H.;Ko, W.-C.;Hwang, K.-P.;Wang, N.-C.;Lee, Y.-L.;Lin, Y.-L.;Shih, Shih S.-R.;Huang, C.-G.;Liao, C.-C.;Liang, J.-J.;Chang, Chang C.-S.;Chen, Chen C.;Lien, C.E.;Tai, I.-C.;Lin, T.-Y. |
显示项目 1-8 / 8 (共1页)
1
每页显示[10|25|50]项目
|
